Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here